Overview
- The Chancellery, led by Chief of Staff Thorsten Frei, convened companies, trade groups, and several ministries to open the talks.
- Officials said the kickoff will fold the existing Pharma Strategy and Pharma Dialogue into one process under the Health Ministry.
- The government aims to design steps to strengthen market conditions and secure supplies after repeated shortages and reliance on production in China and India.
- Industry blames cost pressure and price regulation for pullbacks such as penicillin, while statutory insurers warn that better availability carries costs and call for concrete, fair proposals.
- The BDI welcomed the holistic approach, citing analysis that new technologies could save up to €50 billion annually as insurers note a six percent spending rise in the first half.